Skip to main content
. 2023 Aug 11;12(16):5238. doi: 10.3390/jcm12165238

Table 1.

Demographic information.

Total n = 178
n (%)
Age in years at initiation of atropine
Average (range) 7.8 (2 months–22 years)
<1 year 21 (11.8%)
1–<3 years 26 (14.6%)
3–<12 years 80 (44.9%)
>12 years 51 (28.7%)
Gender
Male 96 (54%)
Female 82 (46%)
Underlying Diagnosis
Cerebral Palsy 98 (55.1%)
Genetic/syndromic disorder 35 (19.7%)
Neuromuscular disease 17 (9.6%)
Neurodegenerative condition 11 (6.2%)
Brain injury 5 (2.8%)
Developmental disorder 4 (2.2%)
Multiple congenital anomalies 4 (2.2%)
Unknown/other 4 (2.2%)